Overvalued Stocks Today 2026

Revolution Medicines, (RVMD) has the largest fair value gap at 99.4% above the modeled estimate, followed by Sunrise Energy Metals (SRL.AX) at 99.4%, Forte Biosciences, (FBRX) at 99.3%, and Oruka Therapeutics, (ORKA) at 99.1%.

Updated todayASX & global marketsRanked by fair value gap

Page snapshot: 17 Oct 2026, 10:06 am

Screen stocks by valuation → · Undervalued stocks → · Stock valuation checker →

Top Overvalued Stocks Today

Company
Revolution Medicines, Inc. logo
Revolution Medicines, Inc.
$177.96
99.42%
$38.14BHealthcare
United States flag
Sunrise Energy Metals Limited logo
Sunrise Energy Metals Limited
$15.73
99.38%
A$2.71BIndustrials
Australia flag
Forte Biosciences, Inc. logo
Forte Biosciences, Inc.
$76.99
99.32%
$1.63BHealthcare
United States flag
Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.
$71.93
99.11%
$4.76BHealthcare
United States flag
Centessa Pharmaceuticals plc logo
Centessa Pharmaceuticals plc
$40.50
98.82%
$6.27BHealthcare
United States flag
Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.
$79.90
98.71%
$7.37BHealthcare
United States flag
Summit Therapeutics Inc. logo
Summit Therapeutics Inc.
$14.63
97.94%
$11.67BHealthcare
United States flag
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.
$29.52
97.70%
$5.12BHealthcare
United States flag
Pulse Biosciences, Inc. logo
Pulse Biosciences, Inc.
$44.43
97.57%
$3.17BHealthcare
United States flag
Tourmaline Bio, Inc. logo
Tourmaline Bio, Inc.
$47.98
97.51%
$1.23BHealthcare
United States flag
NexGen Energy Ltd. logo
NexGen Energy Ltd.
$8.37
97.47%
$5.61BEnergy
United States flag
NexGen Energy Ltd. logo
NexGen Energy Ltd.
$12.39
97.42%
A$8.31BEnergy
Australia flag
Vault Minerals Limited logo
Vault Minerals Limited
$5.94
96.46%
A$6.15BBasic Materials
Australia flag
Scholar Rock Holding Corporation logo
Scholar Rock Holding Corporation
$39.90
96.44%
$4.86BHealthcare
United States flag
Xenon Pharmaceuticals Inc. logo
Xenon Pharmaceuticals Inc.
$33.49
96.25%
$3.24BHealthcare
United States flag
Denali Therapeutics Inc. logo
Denali Therapeutics Inc.
$17.61
96.06%
$2.81BHealthcare
United States flag
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.
$50.31
95.02%
$1.44BHealthcare
United States flag
SELLAS Life Sciences Group, Inc. logo
SELLAS Life Sciences Group, Inc.
$9.98
94.91%
$2.02BHealthcare
United States flag
Dianthus Therapeutics, Inc. logo
Dianthus Therapeutics, Inc.
$72.09
94.55%
$4.03BHealthcare
United States flag
89bio, Inc. logo
89bio, Inc.
$14.84
94.30%
$2.2BHealthcare
United States flag
1-20 of 100

Before you trade on valuation alone

Cross-check fair value with fundamentals, liquidity, and your own goals—this table is a screen, not advice.

Market Insights (Updated Today)

  • Energy shows the highest average fair value gap at 88.7% among sectors with enough coverage on this snapshot.
  • Revolution Medicines, Inc. (RVMD) currently trades at roughly a 99.4% gap versus modeled intrinsic value on our models—rankings can change as prices and inputs update.
  • On average, small-cap names in this list show a larger fair value gap than large caps on today’s snapshot.

Top Overvalued Stocks by Market Cap

Large cap (top 5)

  1. 1.Revolution Medicines, Inc. · RVMD99.4%$38.14B
  2. 2.Summit Therapeutics Inc. · SMMT97.9%$11.67B
  3. 3.Sandisk Corporation · SNDK93.9%$187.78B
  4. 4.Western Digital Corporation · WDC93.5%$124.28B
  5. 5.Seagate Technology Holdings plc · STX92.4%$145.31B

Mid cap (top 5)

  1. 1.Sunrise Energy Metals Limited · SRL.AX99.4%A$2.71B
  2. 2.Oruka Therapeutics, Inc. · ORKA99.1%$4.76B
  3. 3.Centessa Pharmaceuticals plc · CNTA98.8%$6.27B
  4. 4.Spyre Therapeutics, Inc. · SYRE98.7%$7.37B
  5. 5.Cogent Biosciences, Inc. · COGT97.7%$5.12B

Small cap (top 5)

  1. 1.Forte Biosciences, Inc. · FBRX99.3%$1.63B
  2. 2.Tourmaline Bio, Inc. · TRML97.5%$1.23B
  3. 3.Eton Pharmaceuticals, Inc. · ETON95.0%$1.44B
  4. 4.Zenas BioPharma, Inc. · ZBIO88.9%$1.62B
  5. 5.Hycroft Mining Holding Corporation · HYMC84.5%$1.6B

What Are Overvalued Stocks?

They are shares trading above modeled fair (intrinsic) value—shown as a fair value gap versus the current quote. Use this list to scan names where price sits ahead of modeled value at a glance.

Overvaluation is a model-based signal, not a sell recommendation. Open a company page for deeper fundamentals and valuation context before you act.

How We Rank Overvalued Stocks

Names are sorted by fair value gap versus modeled intrinsic value from our valuation-percent feed. The table shows symbol, price, fair value gap, market cap, and sector where the API returns those fields.

Rankings can shift intraday as prices and model inputs move. Use the stock screener or valuation checker for custom filters beyond this overvalued leaderboard.

FAQs

Answers about overvalued names, intrinsic value, and how often this directory refreshes.

What are overvalued stocks?

Overvalued stocks are shares trading above what a valuation model estimates as fair (intrinsic) value—shown as a fair value gap versus price. The gap is a model-based signal, not a guarantee.

How are overvalued stocks ranked on this page?

We rank names from the public valuation-percent feed by fair value gap versus modeled intrinsic value. The table shows price, fair value gap, market cap, and sector where available.

How many stocks are in this overvalued list?

This screen tracks 100 names from ASX, US, and other markets on our valuation snapshot.

Which stock currently has the largest fair value gap on this list?

Revolution Medicines, (RVMD 99.4% fair value gap) has the largest fair value gap on our live snapshot. Rankings shift as prices and model inputs change.

How often does this overvalued stocks list update?

Rankings refresh on a schedule from our servers and can move intraday as quotes and model inputs change. Open a company page for the latest detail.

Is this overvalued stocks list investment advice?

No. Tickerplace provides data and education only. Always validate each symbol on its company page and consider professional advice for personal decisions.

Data updated regularly. Intrinsic value estimates and stock prices are subject to market fluctuations.